Ursprung des Netzwerks ersten Grades von George Addona
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees.
11
| Non-Profit Organization | Miscellaneous Commercial Services | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von George Addona
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Director/Board Member | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| AGILENT TECHNOLOGIES, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| BASF SE | Electrical Products | Corporate Officer/Principal | |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| UCB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| EVOTEC SE | Pharmaceuticals: Major | Chairman | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
| University of Rhode Island | College/University | Doctorate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Corporate Officer/Principal | |
| Peoples' Friendship University of Russia | College/University | Doctorate Degree | |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Aventis Pharma AG | Corporate Officer/Principal | ||
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Research!America is a lobbying firm. The non-profit company is based in Alexandria, VA. The CEO of the company is Mary Woolley. | Miscellaneous Commercial Services | Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Hoechst Marion Roussel, Inc. | Chief Tech/Sci/R&D Officer | ||
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Bristol-Myers Squibb Holdings Pharma LLC
 Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Holdings Pharma Ltd. engages in the pharmaceutical company. The company is headquartered in San Juan, Puerto Rico. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Nebraska-Lincoln | College/University | Undergraduate Degree | |
| BASF Pharma | Corporate Officer/Principal | ||
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| Government-University-Industry Research Roundtable | College/University | Corporate Officer/Principal | |
Verge Analytics, Inc.
 Verge Analytics, Inc. BiotechnologyHealth Technology Verge Analytics, Inc. engages in the provision of biotechnology services. It develops drugs for neurodegenerative diseases using computational genomics. The company was founded by Alice Zhang and Jason Chen in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | Pharmaceuticals: Major | Director/Board Member | |
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Miscellaneous Commercial Services | Director/Board Member | |
| VIMIAN GROUP AB | Biotechnology | Director/Board Member | |
| ALTO NEUROSCIENCE, INC. | Biotechnology | Director/Board Member | |
Transition Bio, Inc.
 Transition Bio, Inc. BiotechnologyHealth Technology Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles. | Biotechnology | Director/Board Member | |
| Frankfurt University Medical School | College/University | Corporate Officer/Principal | |
| American Pancreatic Association Inc. | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 33 |
| Deutschland | 10 |
| Schweden | 3 |
| Vereinigtes Königreich | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Process Industries | 2 |
| Producer Manufacturing | 2 |
Operativ
| Director/Board Member | 80 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 18 |
| Chief Tech/Sci/R&D Officer | 16 |
| Doctorate Degree | 13 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Christy Shaffer | 26 |
| Steven Gilman | 25 |
| Jan Lundberg | 21 |
| Mikael Dolsten | 19 |
| Kelly Huang | 18 |
| Alfred Sandrock | 16 |
| Iris Löw-Friedrich | 15 |
| Aida Habtezion | 11 |
| Mahalakshmi Radhakrishnan | 9 |
| Lori M. Reilly | 4 |
| Patricia A. Seymour | 2 |
- Börse
- Insiders
- George Addona
- Unternehmensverbindungen
